This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Persistent myths and misperceptions regarding long-acting reversible contraception (LARC) raise barriers to wider use of these highly effective methods. While intrauterine devices and the subdermal contraceptive implant provide contraceptive efficacy that is comparable to surgical sterilization, many clinicians remain unduly conservative about which patients may be appropriate candidates for these top-tier methods. This myCME™ Medically Speaking roundtable counters myth and misperception with evidence-based guidance on LARC.
Obstetrician-gynecologists as well as nurse practitioners and physician assistants who provide healthcare for reproductive-aged women
At the conclusion of this activity, participants should be better able to:
Differentiate the long-acting reversible contraceptive (LARC) methods from second- and third-tier methods with regard to efficacy, duration of efficacy, safety, tolerability, and noncontraceptive benefits
Apply the US Medical Eligibility Criteria for Contraceptive Use to identify patients who may be candidates for LARC methods
Assess the evidence regarding use of LARC methods in young and/or nulliparous women
Provide evidence-based patient counseling and education on LARC methods to dispel misperceptions and support informed contraceptive decisions
Conflict Of Interest Disclosure Policies
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Colleen McNicholas, DO, MSci Associate Professor, Obstetrics and Gynecology Washington University School of Medicine St. Louis, MO
Dr. McNicholas has no relevant financial relationships to disclose.
Diana E. Ramos, MD, MPH Adjunct Assistant Clinical Professor Obstetrics and Gynecology Keck University of Southern California Los Angeles, CA
Dr. Ramos has no relevant financial relationships to disclose.
Suzanne L. Reiter, MSN, MM, WHNP-BC, FAANP Past President, National Certification Corporation Women’s Health Nurse Practitioner Director of Professional Development HAB Associates, Inc. Clearwater, FL
Ms. Reiter is a consultant for Hologic, Inc.
Accredited Provider Disclosures
Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 Credit for completing this activity.
Nurse Practitioner Continuing Education AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Bayer HealthCare Pharmaceuticals Inc. or HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.